Found 1 with your filter TargetProtein mono-ADP-ribosyltransferase PARP14 [1611-1801](Homo sapiens (Human))
Ribon Therapeutics
US Patent
Ribon Therapeutics
US Patent
Affinity DataIC50: <1.00E+3nMAssay Description:Enzymatic inhibition of PARP14 was measured using a dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) monitoring the auto-modificati...More data for this Ligand-Target Pair
